A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2002
10/30/2002	EP1251868A1 Combination therapy for the treatment of inflammatory and respiratory diseases
10/30/2002	EP1251852A1 Use of desloratadine for treating allergic and inflammatory conditions
10/30/2002	EP1251851A1 Treating allergic and inflammatory conditions
10/30/2002	EP1251830A1 Continuous method for preparing pharmaceutical granules
10/30/2002	EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002	EP1051425B1 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
10/30/2002	EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002	EP0793660B1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
10/30/2002	EP0695187B1 Inhibition, control and regression of angiogenesis with hyaluronic acid or hyaluronic acid and nsaid
10/30/2002	EP0689449B1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
10/30/2002	CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002	CN1377415A 疫苗组合物 Vaccine composition
10/30/2002	CN1377405A Personal care articles
10/30/2002	CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002	CN1377354A Certain alkylene diamine-substituted pyrazolo [1,5-a]-1,5-pyrimidines and pyrazolo [1,5-a]-1,3,5-triazines
10/30/2002	CN1377353A Purine derivatives having phosphodiesterase IN inhibition activity
10/30/2002	CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002	CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002	CN1377346A Z-pyrazoline-5-ones
10/30/2002	CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002	CN1377278A Prevention and treatment of amyloidogenic disease
10/30/2002	CN1377276A Protein polymerization inhibitors and methods of use
10/30/2002	CN1377269A Vitronectin receptor antagonists
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1377267A Retard form containing 2-lipoic acid (derivatives)
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002	CN1377235A Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
10/30/2002	CN1376677A [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application
10/30/2002	CN1376675A Arginine-aescin with functions of detumescence, relieving inflammation and improving blood circulation and its preapring process
10/30/2002	CN1376670A Arginine-ketoprofen with antalgic and inflammation relieving actions and its preparing process
10/30/2002	CN1376667A Medical compound with antalgic, inflammation relieving and thrombocyte decoagulating actions
10/30/2002	CN1376664A Propynyl or diene diaryl compounds
10/30/2002	CN1376510A Powdered medicine for setting bone and relieving rigidity of tendon and muscles
10/30/2002	CN1376504A Intravenous injection of Chinese angelica root and its preparing process
10/30/2002	CN1376502A Chinese medicine for treating rheumatism
10/30/2002	CN1376493A Exterior-applied plaster for treating appendicitis and its preparing process
10/30/2002	CN1376477A Medicinal bag for relieving rheumatalgia and myalgia
10/30/2002	CN1376476A Wulong Dan for activating collaterals and strengthening tendon and muscles
10/30/2002	CN1376475A Medicine for threating rheumatism, rheumatoid disease, lumbar intervertebral disk protrusion, hyperosteogeny and ischias and its preparing process
10/30/2002	CN1093536C 5-lipoxygenase inhibitor
10/30/2002	CN1093410C Process for preparing medical wine to treat rheumatic arthritis
10/30/2002	CN1093406C Wound healing oil and its preparation
10/30/2002	CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002	US6472562 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
10/29/2002	US6472433 Administering in an animal a dose of atleast 2.5 milligrams of an enantimerically pure r-nonsteroidal anti-inflammatory drugs per kilogram of the animal's body weight for the treatment of inflammation
10/29/2002	US6472418 Non-peptide NK1 receptors antagonists
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472403 αV integrin receptor antagonists
10/29/2002	US6472396 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/29/2002	US6472386 Cyclic diamine compound with 5-membered ring groups
10/29/2002	US6472379 Angiogenesis inhibition
10/29/2002	US6471997 Antagonist of calcitonin gene related peptide, cgrp and/or of substance p; cosmetic
10/29/2002	US6471970 Use of pharmaceutical compositions capable of being gelled in periodontology
10/29/2002	US6471968 Multifunctional nanodevice platform
10/29/2002	US6471959 Human transferase
10/25/2002	EP1194142A4 Salts of cis -4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate!
10/24/2002	WO2002084298A2 Medicaments which are modulators of hm74 and/or hm74a activity
10/24/2002	WO2002084249A2 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083879A2 Immunotherapy based on dendritic cells
10/24/2002	WO2002083874A2 Endothelial cell expression patterns
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002	WO2002083854A2 Antibodies to vla-1
10/24/2002	WO2002083847A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083700A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
10/24/2002	WO2002083696A2 Novel cyclo azaphospha hydrocarbons
10/24/2002	WO2002083693A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
10/24/2002	WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	WO2002083666A1 Substituted benzofuran-2-carboxamides derivatives
10/24/2002	WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083655A1 Prodrugs of cox-2 inhibitors
10/24/2002	WO2002083648A1 Novel 1h-indazole compound
10/24/2002	WO2002083645A1 Novel compounds
10/24/2002	WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002	WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002	WO2002083630A1 Oxalic acid derivatives
10/24/2002	WO2002083627A2 Ligands des integrins avss6
10/24/2002	WO2002083622A2 Novel aminophenyl ketone derivatives
10/24/2002	WO2002083616A1 α-SUBSTITUTED φ-ARYLFATTY ACID DERIVATIVE
10/24/2002	WO2002083186A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
10/24/2002	WO2002083180A1 Elongated and multiple spacers in activatible prodrugs
10/24/2002	WO2002083177A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine
10/24/2002	WO2002083176A2 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
10/24/2002	WO2002083166A1 Interferon-polymer complexes and medicinal use thereof
10/24/2002	WO2002083159A1 Palliative effects of morinda citrifolia oil and juice
10/24/2002	WO2002083155A1 Use of sulfated bacterial polysaccharides suitable for the inhibition of angiogenesis
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002083127A1 Protein modification-inhibitory compositions
10/24/2002	WO2002083122A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation
10/24/2002	WO2002083114A1 Pharmaceutical compositiong or preventing and treating cancer and treating an inflammation
10/24/2002	WO2002083107A1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins
10/24/2002	WO2002083105A2 Composition for enhanced absorption of nsaids
10/24/2002	WO2002083103A2 Pharmaceutical product with reticulated crystalline microstructure
10/24/2002	WO2002083083A2 Pharmaceutically active compounds and methods of use
10/24/2002	WO2002083071A2 Heterocyclic analgesic compounds and methods of use thereof

1 ... 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 ... 1272